Insider Cluster (3 insiders) ·Filed Apr 9, 2026

DNA

Ginkgo Bioworks Holdings, Inc.
BEARISH
Impact 6/10
Horizondays Processed5mo ago
Insider cluster: 3 insiders, $0.9M total
Actionable Insight ▼ Bearish

Traders should watch for further selling pressure or negative news catalysts; the concentration of sales among key insiders, especially a 10% owner, may signal reduced confidence in near-term prospects. Monitor upcoming earnings or pipeline updates.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
DNA ▲ +57.23% at T+60d
SHORT call ✗ call lost -57.23% · α vs SPY -46.45% · entry $6.43 → $10.11
Entry anchored
Apr 8, 03:59 PM ET
via exchange tick
T+1d
+0.31%
call -0.31% · α -0.37%
$6.45
settled 6mo ago
T+5d
+23.64%
call -23.64% · α -20.45%
$7.95
settled 6mo ago
T+20d
+56.77%
call -56.77% · α -49.20%
$10.08
settled 5mo ago
T+60d
+57.23%
call -57.23% · α -46.45%
$10.11
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Three corporate insiders at Ginkgo Bioworks (DNA) conducted open-market share sales over a 7-day period, totaling approximately $870,000 in value. The sales were led by Kelly Jason R, who sold $702K worth of stock, while Shetty Reshma P. and Canton Barry each sold around $84K. These transactions follow larger derivative exercises and sales earlier in the week, indicating a coordinated reduction in holdings.

Key Financial Metrics

Direction
selling
Total Value
$870.0K
Insiders
3

Key Facts

  • Insider cluster involves three individuals: Kelly Jason R, Shetty Reshma P., and Canton Barry (10% owner).
  • Total open-market sales amount to $870,000 over 7 days, with Kelly Jason R accounting for the majority ($702K).
  • Concurrent with multiple non-cash derivative exercises (code M), suggesting option expirations or vesting events.
  • Total selling value represents ~0.22% of DNA's $399M market cap — modest but notable for a small-cap biotech.
  • Sales occurred at prices between $6.397 and $6.93 per share, with average execution near $6.40.

Financial Impact

$870,000 in insider selling over 7 days (~0.22% of market cap)

insider ownershipmarket sentimentdilution perception

Risk Factors

  • Perception of insider pessimism, particularly from a 10% owner
  • Potential for follow-on selling or negative sentiment in a low-liquidity OTC stock

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Genomics & Gene Editing

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DNA-1776114053074
3 reports for DNA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DNA — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
144
NEUTRAL ★ 2/10
$6.99 $7.88▲ +12.73%▲ +11.91%$12.10 (+73.18%)
Apr 9, 2026
25w ago
Insider Cluster
BEARISH ★ 6/10
$6.43 $7.95▼ −23.64%▼ −20.45%$12.10 (−88.26%)
Apr 9, 2026
25w ago
Insider Cluster
BEARISH ★ 6/10
$6.43 $7.95▼ −23.64%▼ −20.45%$12.10 (−88.26%)
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 13, 2026